Ganoderenic acid BCAS# 100665-41-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 100665-41-6 | SDF | Download SDF |
PubChem ID | 91884884 | Appearance | Powder |
Formula | C30H42O7 | M.Wt | 514.65 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (E)-6-[(3S,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid | ||
SMILES | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)C(=O)O | ||
Standard InChIKey | QECQJYAIIIIKJB-IDWWZWRGSA-N | ||
Standard InChI | InChI=1S/C30H42O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h10,16,18-19,21-22,32,34H,8-9,11-14H2,1-7H3,(H,36,37)/b15-10+/t16?,18-,19+,21?,22+,28+,29-,30+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Ganoderenic acid B can enhance the cytotoxicity of chemotherapeutics towards ABCB1-mediated MDR cancer cells via inhibition of the transport function of ABCB1. |
Ganoderenic acid B Dilution Calculator
Ganoderenic acid B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9431 mL | 9.7153 mL | 19.4307 mL | 38.8614 mL | 48.5767 mL |
5 mM | 0.3886 mL | 1.9431 mL | 3.8861 mL | 7.7723 mL | 9.7153 mL |
10 mM | 0.1943 mL | 0.9715 mL | 1.9431 mL | 3.8861 mL | 4.8577 mL |
50 mM | 0.0389 mL | 0.1943 mL | 0.3886 mL | 0.7772 mL | 0.9715 mL |
100 mM | 0.0194 mL | 0.0972 mL | 0.1943 mL | 0.3886 mL | 0.4858 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ganoderenic acid A
Catalog No.:BCN3208
CAS No.:100665-40-5
- Desloratadine
Catalog No.:BCC4540
CAS No.:100643-71-8
- (-)-Epipinoresinol
Catalog No.:BCN3377
CAS No.:10061-38-8
- MK-2894 sodium salt
Catalog No.:BCC1758
CAS No.:1006036-88-9
- MK-2894
Catalog No.:BCC1757
CAS No.:1006036-87-8
- NF 546
Catalog No.:BCC7804
CAS No.:1006028-37-0
- TAK-593
Catalog No.:BCC5142
CAS No.:1005780-62-0
- TC ASK 10
Catalog No.:BCC6301
CAS No.:1005775-56-3
- Monomethylsulochrin
Catalog No.:BCN7255
CAS No.:10056-14-1
- Tirasemtiv
Catalog No.:BCC5183
CAS No.:1005491-05-3
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- CVT 10216
Catalog No.:BCC5606
CAS No.:1005334-57-5
- Ganoderenic acid C
Catalog No.:BCN3210
CAS No.:100665-42-7
- Ganoderenic acid D
Catalog No.:BCN2445
CAS No.:100665-43-8
- Deacetyl ganoderic acid F
Catalog No.:BCN2870
CAS No.:100665-44-9
- 3-(Hydroxymethyl)cyclopentanol
Catalog No.:BCN5822
CAS No.:1007125-14-5
- CH5132799
Catalog No.:BCC4991
CAS No.:1007207-67-1
- 1-O-Deacetylkhayanolide E
Catalog No.:BCN5823
CAS No.:1007387-95-2
- Ganoderic acid M
Catalog No.:BCN2871
CAS No.:100761-17-9
- (R)-5-Hydroxy-1,7-diphenyl-3-heptanone
Catalog No.:BCN3591
CAS No.:100761-20-4
- Chlorahololide C
Catalog No.:BCN7256
CAS No.:1007859-25-7
- 4,4'-Bis(α,α-dimethylbenzyl)diphenylamine
Catalog No.:BCC8661
CAS No.:10081-67-1
- (RS)-CPP
Catalog No.:BCC6561
CAS No.:100828-16-8
- Piceatannol
Catalog No.:BCN5824
CAS No.:10083-24-6
Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells.[Pubmed:25779097]
Int J Oncol. 2015 May;46(5):2029-38.
Chemotherapy is one of the most common therapeutic option for metastatic tumors and hematological malignancies. ABCB1-mediated multidrug resistance is the major obstacle for chemotherapy. Natural products with diversified structures are ideal source of ABCB1 modulators. Ganoderenic acid B, a lanostane-type triterpene isolated from Ganoderma lucidum, exhibited potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to doxorubicin, vincristine and paclitaxel. Similarly, Ganoderenic acid B could also significantly reverse the resistance of ABCB1-overexpressing MCF-7/ADR cells to doxorubicin. Furthermore, Ganoderenic acid B notably enhanced intracellular accumulation of rhodamine-123 in HepG2/ADM cells through inhibition of its efflux. ABCB1 siRNA interference assay indicated that the reversal activity of Ganoderenic acid B was dependent on ABCB1. Further mechanistic investigations found that Ganoderenic acid B did not alter the expression level of ABCB1 and the activity of ABCB1 ATPase. Molecular docking model displayed that the positions of Ganoderenic acid B binding to ABCB1 were different from the region of verapamil interacted with ABCB1. Collectively, Ganoderenic acid B can enhance the cytotoxicity of chemotherapeutics towards ABCB1-mediated MDR cancer cells via inhibition of the transport function of ABCB1. These findings provide evidence that Ganoderenic acid B has the potential to be developed into an ABCB1-mediated multidrug resistance reversal agent.
[Triterpenoids from Ganoderma theaecolum].[Pubmed:28875673]
Zhongguo Zhong Yao Za Zhi. 2016 Mar;41(6):1075-1080.
Fifteenlanostane triterpenoids were isolated from the ethanol extract of Ganoderma theaecolum by means of preparative HPLC,column chromatography over silica gel,ODS and were identified as lucidone C(1),lucidone D(2),7-oxo-ganoderic acid Z2(3),7-oxo-ganoderic acid Z(4),ganoderenicacid H(5),Ganoderenic acid B(6),3beta,7beta-dihydroyl-11,15,23-trioxo-lanost-8,16-dien-26-oic acid(7),3beta,7beta-dihydroyl-11,15,23-trioxo-lanost-8,16-dien-26-oic acid methyl ester(8),ganolucidic acid B(9),ganolucidate F(10),methyl ganoderate C2(11),ganoderic acid zeta(12),ganoderic acid AP3(13),methyl ganoderate B(14),and ganoderol B(15). Compounds 1-15 were isolated from this specie for the first time.